EQUAL pocket cards on Candidiasis, Aspergillosis, and Mucormycosis now available in Russian
Date | 22-08-2018

EQUAL pocket cards on Candidiasis, Aspergillosis, and Mucormycosis in Hematology Patients now are available in Russian. EQUAL Candida 2018 Sept ru final_DOI EQUAL Aspergillosis 2018 ru Sept final_DOI EQUAL Mucor 2018 ru Sept final_DOI

EQUAL Score Card for Mucormycosis now available in Polish
Date | 20-08-2018

For Mucormycosis an EQUAL pocket card is available in Polish: EQUAL Mucor 2018 pl Sept final_DOI DOI: 10.4126/FRL01-006409360

New FECMM paper on the role of Antifungal Combination Therapy for Lomentospora Prolificans and other Rare Mold Infections
Date | 16-08-2018

Highlights Retrospective analysis of patients diagnosed with non-Aspergillus invasive mold infections at the University of California San Diego Medical Center, San Diego, California, United States. IMIs occurred in patients with a variety of underlying diseases and diverse sites, not just …

FORWARD Act for antifungals. New US initiative: Finding Orphan-disease Remedies with Antifungal Research & Development
Date | 13-08-2018

New US initiative: Finding Orphan-disease Remedies with Antifungal Research & Development A bill was introduced to support endemic orphan fungal disease research, incentivize Valley Fever vaccine development, discover new antifungal therapies and diagnostics, and for other purposes. full document: FORWARD BILLS-115hr6562ih

Global Guidelines and Initiatives from the ECMM to improve Patient Care and Research Worldwide: New Leadership is about Working Together
Date | 13-08-2018

Invasive mycoses present a global challenge with expansion into new hosts, emergence of new pathogens, and development of multidrug resistance. In parallel, new antifungal agents and advanced laboratory diagnostic systems are being developed. In response to these evolving challenges, the …